NIFTY 50 23415.15 ▲ (0.3%)
NIFTY NEXT 50 65001.65 ▼ (0.16%)
NIFTY 100 24101.2 ▲ (0.22%)
NIFTY MIDCAP 100 55118.45 ▲ (0.02%)
NIFTY SMALLCAP 100 17936.45 ▲ (0.4%)
NIFTY SMALLCAP 250 16918.6 ▲ (0.46%)
NIFTY MIDCAP SELECT 12325.1 ▼ (0.25%)
NIFTY TOTAL MARKET 12335.95 ▲ (0.25%)
NIFTY BANK 49318.85 ▼ (0.06%)
SENSEX 77176.46 ▲ (0.13%)
BSE BANKEX 55964.97 ▼ (0.13%)

Tejnaksh Healthcare Reports Q2: Revenue Up by 8.96% Year-on-Year

[fetch_key]

Highlights

  • The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
  • Sales over the Year and quarter: The company experienced a substantial growth of 8.96 % in the past year, substantial increase in net sales/revenue by 7.84 %.
  • Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 4.88 %. Marginal increase in other income during this quarter, up by 19.44%.
  • Profit over the Year and quarter: Significant improvement in profitability for Tejnaksh Healthcare Limited. Notable increase of 6.87 % in net profit Year to Year, Tejnaksh Healthcare Limited’s profitability increased by 9.02 % in this quarter.
  • EPS over the Year and quarter: EPS increased by 6.90 % Year to Year. EPS increased by 6.9 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of Tejnaksh Healthcare Limited‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 3.092 Cr Rs. 3.124 Cr Rs. 3.369 Cr + 7.84 % + 8.96 %
Expenses Rs. 1.96 Cr Rs. 2.05 Cr Rs. 2.21 Cr + 7.8 % + 12.76 %
Operating Profit Rs. 1.13 Cr Rs. 1.07 Cr Rs. 1.16 Cr + 8.41 % + 2.65 %
OPM % 36.55 % 34.25 % 34.43 % + 0.18 % -2.12 %
Other Income Rs. 0.082 Cr Rs. 0.072 Cr Rs. 0.086 Cr + 19.44 % + 4.88 %
Interest Rs. 0.16 Cr Rs. 0.12 Cr Rs. 0.11 Cr -8.33 % -31.25 %
Depreciation Rs. 0.23 Cr Rs. 0.23 Cr Rs. 0.31 Cr + 34.78 % + 34.78 %
Profit before tax Rs. 0.82 Cr Rs. 0.79 Cr Rs. 0.83 Cr + 5.06 % + 1.22 %
Tax % 26.03 % 25.13 % 21.3 % -3.83 % -4.73 %
Net Profit Rs. 0.61 Cr Rs. 0.6 Cr Rs. 0.65 Cr + 8.33 % + 6.56 %
EPS in Rs Rs. 0.29 Rs. 0.29 Rs. 0.31 + 6.9 % + 6.9 %


Today, we’re looking at Tejnaksh Healthcare Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 8.96 %. However, it did see a marginal increase of 7.84 % from the previous quarter. Expenses ticked up slightly by 7.8 % quarter-on-quarter, aligning with the annual rise of 12.76 %. Operating profit, while up 2.65 % compared to last year, faced a quarter-on-quarter increase of 8.41 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -2.12 %, but an expansion of 0.18 % sequentially. Other income rose by 19.44 % compared to the last quarter, despite an annual growth of 4.88 %. Interest expenses dropped significantly by -8.33 % from the previous quarter, yet the year-over-year decrease remains at a moderate -31.25 %. Depreciation costs climbed by 34.78 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 34.78 %. Profit before tax grew annually by 1.22 % but saw an increase from the preceding quarter by 5.06 %.
Tax expenses as a percentage of profits decreased slightly by -4.73 % compared to last year, with a more notable quarter-on-quarter decrease of -3.83 %. Net profit rose by 6.56 % year-on-year but experienced a 8.33 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 6.9 % but a quarterly rise of 6.9 %. In summary, Tejnaksh Healthcare Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 3.092 Cr Rs. 3.124 Cr Rs. 3.369 Cr + 7.84 % + 8.96 %
Expenses Rs. 1.96 Cr Rs. 2.05 Cr Rs. 2.21 Cr + 7.8 % + 12.76 %
Operating Profit Rs. 1.13 Cr Rs. 1.07 Cr Rs. 1.16 Cr + 8.41 % + 2.65 %
Net Profit Rs. 0.61 Cr Rs. 0.6 Cr Rs. 0.65 Cr + 8.33 % + 6.56 %
EPS in Rs Rs. 0.29 Rs. 0.29 Rs. 0.31 + 6.9 % + 6.9 %


In reviewing Tejnaksh Healthcare Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 8.96 % year-on-year growth, however, there was a minor increase of 7.84 % from the previous quarter. Expenses rose by 12.76 % compared to the previous year, with a 7.8 % increase quarter-on-quarter. Operating Profit surged by 2.65 % annually, and saw a 8.41 % increase from the last quarter.
Net Profit showed yearly increase of 6.56 %, and experienced a 8.33 % increase from the previous quarter. Earnings Per Share (EPS) rose by 6.9 % annually, however rose by 6.9 % compared to the last quarter. In essence, while Tejnaksh Healthcare Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Tejnaksh Healthcare Limited”]

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post